Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Encode Pharmaceuticals

2002 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of products for treatment of metabolic and neurodegenerative diseases. The company produces EC Cysteamine, an enterically coated formulation of cysteamine bitartrate.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • CA
  • United States

Encode Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Encode Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook